Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

AZD 6244 × Tumor-Agnostic × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 9 Thoracic 2 Tumor-Agnostic 1 Sarcoma 1 Other hematologic neoplasm 1 Myeloid 1 Genitourinary 1 Dermatologic 1 Breast 1

Conditions

Interventions

pembrolizumab 20 Specimen Handling 18 Biopsy 16 Magnetic Resonance Spectroscopy 13 Paclitaxel 12 atezolizumab 9 Standard of Care 9 Nivolumab 8 Oxaliplatin 7 Interviews as Topic 7 Bevacizumab 7 Surveys and Questionnaires 6 trastuzumab deruxtecan 5 Taxes 5 Fluorouracil 5 Cyclophosphamide 5 Carboplatin 5 Blood Specimen Collection 5 tislelizumab 4 niraparib 4 Radiotherapy 4 Practice Guidelines as Topic 4 Methods 4 Leucovorin 4 Irinotecan 4 Gemcitabine 4 Fulvestrant 4 Focus Groups 4 Everolimus 4 Educational Status 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02813135 2026-01-16

ESMART

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1/2 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡